Tibet Rhodiola Pharmaceutical Holding Dividends and Buybacks
Dividend criteria checks 5/6
Tibet Rhodiola Pharmaceutical Holding is a dividend paying company with a current yield of 4.03% that is well covered by earnings.
Key information
4.0%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 7.2% |
| Dividend Growth | 20.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥1.534 |
| Payout ratio | 67% |
Recent dividend and buyback updates
No updates
Recent updates
At CN¥33.30, Is Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Worth Looking At Closely?
Sep 25
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Could Easily Take On More Debt
Sep 02Insufficient Growth At Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Hampers Share Price
Jul 29Investors Shouldn't Overlook Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Impressive Returns On Capital
Jul 12Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Seems To Use Debt Rather Sparingly
May 21Shareholders Will Be Pleased With The Quality of Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Earnings
May 03Under The Bonnet, Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Returns Look Impressive
Mar 22Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 600211's dividend payments have been volatile in the past 10 years.
Growing Dividend: 600211's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Tibet Rhodiola Pharmaceutical Holding Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (600211) | 4.0% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Healthcare) | 1.7% |
| Analyst forecast (600211) (up to 3 years) | 7.2% |
Notable Dividend: 600211's dividend (4.03%) is higher than the bottom 25% of dividend payers in the CN market (0.53%).
High Dividend: 600211's dividend (4.03%) is in the top 25% of dividend payers in the CN market (2.09%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (66.9%), 600211's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (48.9%), 600211's dividend payments are well covered by cash flows.